160 related articles for article (PubMed ID: 33581994)
1. Early axonal loss predicts long-term disability in chronic inflammatory demyelinating polyneuropathy.
Al-Zuhairy A; Jakobsen J; Krarup C
Clin Neurophysiol; 2021 Apr; 132(4):1000-1007. PubMed ID: 33581994
[TBL] [Abstract][Full Text] [Related]
2. Axonal loss at time of diagnosis as biomarker for long-term disability in chronic inflammatory demyelinating polyneuropathy.
Al-Zuhairy A; Jakobsen J; Moldovan M; Krarup C
Muscle Nerve; 2022 Dec; 66(6):715-722. PubMed ID: 36217677
[TBL] [Abstract][Full Text] [Related]
3. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
4. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
[TBL] [Abstract][Full Text] [Related]
5. Quantitative muscle ultrasound is useful for evaluating secondary axonal degeneration in chronic inflammatory demyelinating polyneuropathy.
Hokkoku K; Matsukura K; Uchida Y; Kuwabara M; Furukawa Y; Tsukamoto H; Hatanaka Y; Sonoo M
Brain Behav; 2017 Oct; 7(10):e00812. PubMed ID: 29075571
[TBL] [Abstract][Full Text] [Related]
6. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
7. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356
[TBL] [Abstract][Full Text] [Related]
8. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
Chin RL; Latov N; Sander HW; Hays AP; Croul SE; Magda P; Brannagan TH
J Peripher Nerv Syst; 2004 Sep; 9(3):132-7. PubMed ID: 15363060
[TBL] [Abstract][Full Text] [Related]
9. Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
Attarian S; Franques J; Elisabeth J; Trébuchon A; Duclos Y; Wybrecht D; Verschueren A; Salort-Campana E; Pouget J
Muscle Nerve; 2015 Apr; 51(4):541-8. PubMed ID: 25571892
[TBL] [Abstract][Full Text] [Related]
10. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
[TBL] [Abstract][Full Text] [Related]
11. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
[TBL] [Abstract][Full Text] [Related]
12. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Lozeron P; Mariani LL; Dodet P; Beaudonnet G; Théaudin M; Adam C; Arnulf B; Adams D
Neurology; 2018 Jul; 91(2):e143-e152. PubMed ID: 29907605
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
14. Sensory nerve conduction slowing is a specific marker for CIDP.
Bragg JA; Benatar MG
Muscle Nerve; 2008 Dec; 38(6):1599-603. PubMed ID: 19016547
[TBL] [Abstract][Full Text] [Related]
15. Magnetically evoked motor potentials in demyelinating and axonal polyneuropathy: a comparative study.
Takada H; Ravnborg M
Eur J Neurol; 2000 Jan; 7(1):63-9. PubMed ID: 10809916
[TBL] [Abstract][Full Text] [Related]
16. Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX.
Paramanathan S; Tankisi H; Andersen H; Fuglsang-Frederiksen A
Clin Neurophysiol; 2016 Jan; 127(1):898-904. PubMed ID: 26049677
[TBL] [Abstract][Full Text] [Related]
17. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
18. Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.
Garg N; Park SB; Howells J; Vucic S; Yiannikas C; Mathey EK; Nguyen T; Noto Y; Barnett MH; Krishnan AV; Spies J; Bostock H; Pollard JD; Kiernan MC
Eur J Neurol; 2019 Aug; 26(8):1121-1129. PubMed ID: 30882969
[TBL] [Abstract][Full Text] [Related]
19. [Role of short-latency somatosensory evoked potential in the diagnosis of chronic inflammatory demyelinating polyneuropathy].
Sun RD; Fu B; Jiang J
Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):545-548. PubMed ID: 28506346
[TBL] [Abstract][Full Text] [Related]
20. Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatment.
Pegat A; Boisseau W; Maisonobe T; Debs R; Lenglet T; Psimaras D; Azoulay-Cayla A; Fournier E; Viala K
J Peripher Nerv Syst; 2020 Jun; 25(2):162-170. PubMed ID: 32364302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
